ProShares Trust - ProShares UltraPro Nasdaq Biotechnology

As of April 3, 2020, ProShares Trust - ProShares UltraPro Nasdaq Biotechnology has gone out of business. ProShares Trust - ProShares UltraPro Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. The fund invests directly and through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the Nasdaq Biotechnology Index, by using synthetic replication technique. ProShares Trust - ProShares UltraPro Nasdaq Biotechnology was formed on June 22, 2015 and is domiciled in the United States.